Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
Add more filters

Complementary Medicines
Country/Region as subject
Publication year range
1.
Drug Deliv ; 28(1): 2187-2197, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34662244

ABSTRACT

Rhizoma polygonati (Huangjing, RP) has been used for a long history with many chemical components in inducing anti-cancer, anti-aging, anti-diabetes, anti-fatigue, and more prevention of diseases or acts as nutrition sources in food. Here we investigated RP extract combination with kinase inhibitors in anti-cell growth and blockade in pathways targeting kinases. Experimental investigation and network pharmacology analysis were applied to test the potent kinase-mediated signaling. Herbzyme activity was determined by substrate with optical density measurement. Extract of processed RP inhibits cell growth in a much greater manner than alone when applied in combination with inhibitors of mTOR or EGFR. Moreover, processing methods of RP from Mount Tai (RP-Mount Tai) play essential roles in herbzyme activity of phosphatase suggesting the interface is also essential, in addition to the chemical component. The network pharmacology analysis showed the chemical component and target networks involving AKT and mTOR, which is consistent with experimental validation. Finally, EGFR inhibitor could be associated with nano-extract of RP-Mount Tai but not significantly affects the phosphatase herbzyme activity in vitro. Thus the processed extract of RP-Mount Tai may play a dual role in the inhibition of cell proliferation signaling by both chemical component and nanoscale herbzyme of phosphatase activity to inhibit kinases including mTOR/AKT in potent drug delivery of kinase inhibitors.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Network Pharmacology/methods , Plant Extracts/pharmacology , Polygonatum , Cell Enlargement/drug effects , Cell Line, Tumor , Humans , Protein Interaction Maps , Proto-Oncogene Proteins c-akt/drug effects , TOR Serine-Threonine Kinases/drug effects
2.
Biochem Biophys Res Commun ; 558: 154-160, 2021 06 18.
Article in English | MEDLINE | ID: mdl-33915329

ABSTRACT

Genistein, a naturally occurring phytoestrogen and a member of the large class of compounds known as isoflavones, exerts protective effects in several diseases. Recent studies indicate that genistein plays a critical role in controlling body weight, obesity-associated insulin resistance, and metabolic disorders, but its target organs in reversing obesity and related pathological conditions remain unclear. In this study, we showed that mice supplemented with 0.2% genistein in a high-fat diet for 12 weeks showed enhanced metabolic homeostasis, including reduced obesity, improved glucose uptake and insulin sensitivity, and alleviated hepatic steatosis. We also observed a beiging phenomenon in the white adipose tissue and reversal of brown adipose tissue whitening in these mice. These changes led to enhanced resistance to cold stress. Altogether, our data suggest that the improved metabolic profile in mice treated with genistein is likely a result of enhanced adipose tissue function.


Subject(s)
Adipose Tissue, Beige/drug effects , Adipose Tissue, Beige/metabolism , Cold-Shock Response/drug effects , Cold-Shock Response/physiology , Genistein/pharmacology , Adipocytes, White/cytology , Adipocytes, White/drug effects , Adipose Tissue, Brown/drug effects , Adipose Tissue, Brown/metabolism , Adipose Tissue, White/drug effects , Adipose Tissue, White/metabolism , Animals , Body Weight/drug effects , Cell Enlargement/drug effects , Diet, High-Fat/adverse effects , Eating/drug effects , Energy Metabolism/drug effects , Insulin Resistance/physiology , Male , Mice , Mice, Inbred C57BL , Obesity/drug therapy , Obesity/metabolism , Obesity/pathology , Phytoestrogens/pharmacology , Protective Agents/pharmacology
3.
Neuroreport ; 31(13): 971-978, 2020 09 09.
Article in English | MEDLINE | ID: mdl-32694311

ABSTRACT

We recently reported that upregulation of the constitutively active ras homolog enriched in brain [Rheb(S16H)], which induces the activation of the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway, can protect adult neurons, mediated by the induction of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), in animal models of neurodegenerative diseases. Here we show that neuronal transduction of Rheb(S16H) using adeno-associated virus serotype 1 provides neuroprotection in a mouse model of photothrombosis-induced ischemic stroke. Rheb(S16H)-expressing neurons exhibited neurotrophic effects, such as mTORC1 activation, increases in neuronal size, and BDNF production, in mouse cerebral cortex. Moreover, the upregulation of neuronal Rheb(S16H) significantly attenuated ischemic damage and behavioral impairments as compared to untreated mice, suggesting that Rheb(S16H) upregulation in cortical neurons may be a useful strategy to treat ischemic stroke.


Subject(s)
Motor Cortex/metabolism , Neurons/metabolism , Neuroprotection/genetics , Ras Homolog Enriched in Brain Protein/genetics , Thrombotic Stroke/genetics , Animals , Brain-Derived Neurotrophic Factor/metabolism , Cell Enlargement , Dependovirus , Disease Models, Animal , Fluorescent Dyes , Gait Analysis , Gene Transfer Techniques , Genetic Vectors , Ischemic Stroke/genetics , Ischemic Stroke/metabolism , Ischemic Stroke/pathology , Ischemic Stroke/physiopathology , Mice , Motor Cortex/pathology , Mutation , Neurons/pathology , Rose Bengal , Thrombotic Stroke/metabolism , Thrombotic Stroke/pathology , Thrombotic Stroke/physiopathology , Transduction, Genetic
4.
Environ Toxicol ; 35(12): 1343-1351, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32686902

ABSTRACT

As a traditional plant medicine in tropical areas, Swietenia macrophylla seeds are usually applied for some chronic diseases, including hypertension, diabetes, and so on. Few studies have been carried out to identify the effective elements in seed extract and their indications. In this study, we first investigated the functions of the swietenine, an extract from S. macrophylla seeds, using a model of myocardial hypertrophy induced by isoprenaline (ISO). At cellular level, H9c2 cell hypertrophy was also established through the treatment with ISO. The cardiac pathological remodeling was evaluated by echocardiography and histological analysis. Western blot and RT-qPCR were used to detect the expression of possible hypertrophy-promoting genes. Here, our results indicated that swietenine remarkably attenuated ISO-induced myocardial hypertrophy in vivo and in vitro. Moreover, Akt phosphorylation, ANP and BNP mRNA expression were efficiently decreased. Based on these findings, we concluded that swietenine might be a promising anti-hypertrophic agent against cardiac hypertrophy.


Subject(s)
Cardiomegaly/prevention & control , Heart/drug effects , Limonins/pharmacology , Meliaceae/chemistry , Plant Extracts/pharmacology , Animals , Cardiomegaly/chemically induced , Cell Enlargement/drug effects , Cell Line , Cell Survival/drug effects , Isoproterenol/adverse effects , Limonins/isolation & purification , Male , Mice , Myocardium/metabolism , Myocardium/pathology , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/pathology , Organ Size/drug effects , Plant Extracts/isolation & purification , Rats , Seeds/chemistry
5.
Environ Toxicol ; 35(10): 1043-1049, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32415908

ABSTRACT

In this study, we used ICI 182 780 (ICI), an estrogen receptor (ER) antagonist, to investigate the estrogenic activity of Danshen, and to further explored whether Danshen extract can block Leu27IGF-II-induced hypertrophy in H9c2 cardiomyoblast cells. We first used an IGF-II analog Leu27IGF-II, which specifically activates IGF2R signaling cascades and induces H9c2 cardiomyoblast cell hypertrophy. However, Danshen extract completely inhibited Leu27IGF-II-induced cell size increase, ANP and BNP hypertrophic marker expression, and IGF2R induction. We also observed that Danshen extract inhibited calcineurin protein expression and NFAT3 nuclear translocation, leading to suppression of Leu27IGF-II-induced cardiac hypertrophy. Moreover, the anti-Leu27IGF-II-IGF2R signaling effect of Danshen was totally reversed by ICI, which suggest the cardio protective effect of Danshen is mediated through estrogen receptors. Our study suggests that, Danshen exerts estrogenic activity, and thus, it could be used as a selective ER modulator in IGFIIR induced hypertrophy model.


Subject(s)
Cell Enlargement/drug effects , Drugs, Chinese Herbal/pharmacology , Insulin-Like Growth Factor II/analogs & derivatives , Myoblasts, Cardiac/drug effects , Receptor, IGF Type 2/metabolism , Salvia miltiorrhiza/chemistry , Animals , Calcineurin/metabolism , Cardiomegaly/prevention & control , Cell Line , Cell Survival/drug effects , Drugs, Chinese Herbal/isolation & purification , Estrogen Receptor Antagonists/pharmacology , Fulvestrant/pharmacology , Insulin-Like Growth Factor II/pharmacology , Myoblasts, Cardiac/metabolism , Myoblasts, Cardiac/pathology , Protein Transport , Rats , Receptors, Estrogen/metabolism , Signal Transduction
6.
Plant Mol Biol ; 103(1-2): 91-111, 2020 May.
Article in English | MEDLINE | ID: mdl-32043226

ABSTRACT

KEY MESSAGE: Auxin treatment of grape (Vitis vinifera L.) berries delays ripening by inducing changes in gene expression and cell wall metabolism and could combat some deleterious climate change effects. Auxins are inhibitors of grape berry ripening and their application may be useful to delay harvest to counter effects of climate change. However, little is known about how this delay occurs. The expression of 1892 genes was significantly changed compared to the control during a 48 h time-course where the auxin 1-naphthaleneacetic acid (NAA) was applied to pre-veraison grape berries. Principal component analysis showed that the control and auxin-treated samples were most different at 3 h post-treatment when approximately three times more genes were induced than repressed by NAA. There was considerable cross-talk between hormone pathways, particularly between those of auxin and ethylene. Decreased expression of genes encoding putative cell wall catabolic enzymes (including those involved with pectin) and increased expression of putative cellulose synthases indicated that auxins may preserve cell wall structure. This was confirmed by immunochemical labelling of berry sections using antibodies that detect homogalacturonan (LM19) and methyl-esterified homogalacturonan (LM20) and by labelling with the CMB3a cellulose-binding module. Comparison of the auxin-induced changes in gene expression with the pattern of these genes during berry ripening showed that the effect on transcription is a mix of changes that may specifically alter the progress of berry development in a targeted manner and others that could be considered as non-specific changes. Several lines of evidence suggest that cell wall changes and associated berry softening are the first steps in ripening and that delaying cell expansion can delay ripening providing a possible mechanism for the observed auxin effects.


Subject(s)
Cell Wall/drug effects , Indoleacetic Acids/pharmacology , Plant Cells/drug effects , Plant Growth Regulators/pharmacology , Vitis/drug effects , Cell Enlargement/drug effects , Cell Wall/genetics , Fruit/drug effects , Fruit/growth & development , Gene Expression Regulation, Plant/drug effects , Naphthaleneacetic Acids/pharmacology , Plant Cells/physiology , Time , Vitis/growth & development
7.
J Plant Physiol ; 237: 104-110, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31055228

ABSTRACT

Biophysical fruit growth depends on a balance among the vascular and transpiration flows entering/exiting the fruit via phloem, xylem and through the epidermis. There is no information on vascular flows of Japanese plums, a species characterized by high-sugar content of its fruit at harvest. Vascular flows of Angeleno plums were monitored by fruit gauges during late fruit development, under the dry environment of the Goulburn Valley, Victoria, Australia. Phloem, xylem flows and skin transpiratory losses were determined, as well as diurnal leaf, stem and fruit pressure potentials. Fruit seasonal development, skin conductance and dry matter accumulation were also monitored. Fruit grew following a double-sigmoid pattern, but fruit size increased only 3.1 g over the last 3 weeks of development. Fruit grew very little in the morning, primarily due to phloem inflows (0.05 g fruit-1hr-1), while water left the fruit via the xylem. Negligible skin transpiration was recorded for vapour pressure deficit (VPD) values below 3 kPa. This growth pattern, in the absence of skin transpiration, suggests apoplastic phloem unloading. However, at VPD values over 3 kPa (e.g. from early afternoon to a peak around 18:00 h), transpiratory losses through the skin (up to 0.25 g fruit-1hr-1) caused fruit to shrink, leading to enhanced phloem and xylem inflows (ca. 0.15 g fruit-1hr-1), a scenario that would correspond to symplastic phloem unloading. Over 24 h the fruit showed a slightly negative total growth, consistent with fruit growth measured in situ during the season at weekly intervals. A few fruit species are known to alter their phloem unloading mechanism, switching from symplastic to apoplastic during the season. Our data support the coexistence in Japanese plum of different phloem unloading strategies within the same day.


Subject(s)
Phloem/physiology , Plant Transpiration/physiology , Prunus domestica/physiology , Cell Enlargement , Environment , Fruit/growth & development , Fruit/physiology , Victoria
8.
Am J Chin Med ; 47(2): 337-350, 2019.
Article in English | MEDLINE | ID: mdl-30871360

ABSTRACT

Through population-based studies, associations have been found between coffee drinking and numerous health benefits, including a reduced risk of cardiovascular disease. Active ingredients in coffee have therefore received considerable attention from researchers. A wide variety of effects have been attributed to cafestol, one of the major compounds in coffee beans. Because cardiac hypertrophy is an independent risk factor for cardiovascular events, this study examined whether cafestol inhibits urotensin II (U-II)-induced cardiomyocyte hypertrophy. Neonatal rat cardiomyocytes were exposed only to U-II (1 nM) or to U-II (1 nM) following 12-h pretreatment with cafestol (1-10 µ M). Cafestol (3-10 µ M) pretreatment significantly inhibited U-II-induced cardiomyocyte hypertrophy with an accompanying decrease in U-II-induced reactive oxygen species (ROS) production. Cafestol also inhibited U-II-induced phosphorylation of redox-sensitive extracellular signal-regulated kinase (ERK) and epidermal growth factor receptor transactivation. In addition, cafestol pretreatment increased Src homology region 2 domains-containing phosphatase-2 (SHP-2) activity, suggesting that cafestol prevents ROS-induced SHP-2 inactivation. Moreover, nuclear factor erythroid-2-related factor 2 (Nrf2) translocation and heme oxygenase-1 (HO-1) expression were enhanced by cafestol. Addition of brusatol (a specific inhibitor of Nrf2) or Nrf2 siRNA significantly attenuated cafestol-mediated inhibitory effects on U-II-stimulated ROS production and cardiomyocyte hypertrophy. In summary, our data indicate that cafestol prevented U-II-induced cardiomycyte hypertrophy through Nrf2/HO-1 activation and inhibition of redox signaling, resulting in cardioprotective effects. These novel findings suggest that cafestol could be applied in pharmacological therapy for cardiac diseases.


Subject(s)
Cell Enlargement/drug effects , Diterpenes/pharmacology , Myocytes, Cardiac/pathology , NF-E2-Related Factor 2/metabolism , Urotensins/adverse effects , Urotensins/antagonists & inhibitors , Animals , Cardiomegaly/drug therapy , Cells, Cultured , Depression, Chemical , Diterpenes/therapeutic use , ErbB Receptors/genetics , Extracellular Signal-Regulated MAP Kinases/metabolism , Heme Oxygenase-1/metabolism , Phosphorylation/drug effects , Phytotherapy , Protein Tyrosine Phosphatase, Non-Receptor Type 11/metabolism , Rats , Reactive Oxygen Species/metabolism , Transcriptional Activation/drug effects
9.
São Paulo; s.n; s.n; 2019. 32 p. tab, graf.
Thesis in English | LILACS | ID: biblio-1361457

ABSTRACT

Microalgae, photosynthetic microorganisms, are rich in lipids, polyunsaturated fatty acids, carbohydrates, proteins, vitamins, as well as carotenoids, which are antioxidants that may protect human body from various diseases including obesity, cardiovascular disease, vision-related diseases such as macular degeneration and certain types of cancer. These natural pigments have applications in the pharmaceutical (nutraceutical), food (coloring, functional food, and supplements), and cosmetics industries (e.g. sunscreen), as well as in aquaculture (animal feed). The Dunaliella salina microalga can synthesize 10% of dry weight in ß-carotene (orange pigment, pro-vitamin A activity) under high light intensity and nitrogen and phosphorus limitation, among other stress conditions. The first chapter of this thesis presents a review focused on microalgae carotenoids: culture systems, mode of operation, and applications. In this bibliographic survey, the advantages of microalgae cultivation in relation to traditional sources (higher plants) were discussed, as well as a discussion of the main cultivation systems and their importance in cell growth. This review presented a critical analysis of the different operational regimes like batch, fed-batch, semi-continuous and continuous. Relevant information on the most important world producers of microalgae carotenoids were presented. Chapter II presents the development of a modified method of dispersive liquid-liquid microextraction (DLLME) for rapid extraction of ß-carotene from Dunaliella salina cultivated in tubular photobioreactor, with subsequent development of a rapid chromatographic screening method using a C4 column for separation of geometric isomer of ß-carotene. The use of benzene as extraction solvent and water with 50% acetone as dispersant provided the best condition for the extraction of this carotenoid. In HPLC (High Performance Liquid Chromatography), employing mobile phase composed of methanol and water (95:5, v/v), it was possible to detect/quantify ß-carotene at 14 min (retention time). Besides the short analysis time (<20 min), by the miniaturized extraction (< 10 mL organic waste) this method abide by green chemistry analytical principles. It is known that nitrogen, phosphorus, as well as carbon and vitamins are vital elements for the growth of microalgae, also determining the biochemical composition of biomass. In this sense, Chapter III presents the study of the influence of different amounts of sodium nitrate (1N = 75 mg L-1; 1.5N = 112.5 mg L-1, and 3N = 225 mg L-1) and phosphate monobasic dehydrate (1P = 5.65 mg L-1, 1.5P = 8.47 mg L-1, and 3P = 16.95 mg L-1) in seawater-based f/2 medium on the growth of Dunaliella salina and ß-carotene biosynthesis, by continuous process with different replenishment proportions (R = 20% and 80%). Best results of cell productivity were obtained by semicontinuous process (mean values of Px up to 6.7 x 104 cells mL-1 d-1 with medium 1N:1P; R =20%) in comparison with batch process cultivation. Maximum cell density (Xm) obtained in this work was not dependent of R, but the best results were obtained when using medium 1.5N:1.5P (mean values up to 5.6 x 105 cells mL-1 with R =80%) instead of 1N:1P. The content of ß-carotene in the cells, in general, was higher in cells grown in medium 1N:1P (mean yield values up to 57.5 mg g-1 with R =80%) in comparison with medium 1.5N:1.5P. The cultivation of D. salina with media 3N:3P led to a long lag phase, followed by decrease in cell density and cell lysis. The use of a tubular photobioreactor contributed to successfully cultivate this microalga without contamination by protozoa. The cultivation of Dunaliella salina in tubular photobioreactor with the use of 12:12 photoperiod was appropriate, as well as to induce carotenogenesis, in the second stage, by increasing the light intensity and absence of pH control


As microalgas, micro-organismos fotossintetizantes, são ricas em lipídios, ácidos graxos poli-insaturados, carboidratos, proteínas, vitaminas, além de carotenoides que são antioxidantes com potencial de proteger o organismo humano de várias doenças incluindo a obesidade, doenças cardiovasculares, doenças relacionadas à visão como a degeneração macular e certos tipos de câncer, entre outras. Esses pigmentos naturais têm aplicações em indústrias farmacêuticas (nutracêuticos), alimentícias (colorantes, alimentos funcionais e suplementos) e de cosméticos (exemplo: filtro solar) e na aquacultura (ração animal). A microalga Dunaliella salina é capaz de sintetizar, sob alta intensidade luminosa e limitação de nutrientes como fontes de fósforo e nitrogênio, dentre outras condições de estresse, 10 % do peso seco em ß-caroteno (pigmento laranja com atividade pró-vitamina A). Assim, neste trabalho, numa primeira etapa, foi feita uma revisão da literatura abordando a produção de carotenoides por microalgas, bem como sua aplicação. Nesse levantamento bibliográfico abordou-se, dentre outros assuntos, as vantagens do cultivo de microalgas em relação as fontes tradicionais (plantas superiores), assim como uma discussão dos diferentes sistemas de cultivos e sua importância no crescimento celular. Esse review apresentou uma análise crítica dos principais regimes operacionais como batch, fed-batch, semicontínuo e contínuo. Apresentou-se também informações relevantes sobre os mais importantes produtores mundiais de carotenoides de microalgas. Numa segunda etapa, foi desenvolvido um método modificado de microextração líquido-líquido dispersivo modificado (DLLME) para a rápida extração de ß-caroteno de Dunaliella salina cultivada em fotobiorreatores tubulares, com subsequente desenvolvimento de método cromatográfico em uma coluna C4 para a separação do isômero geométrico de ß-caroteno. A extração ótima de ß-caroteno foi obtida com benzeno como solvente extrator e água com 50% de acetona como dispersante. Empregando uma fase móvel composta por metanol e água (95:5, v/v) em HPLC, foi possível a detecção/quantificação de ß-caroteno com 14 minutos de tempo de retenção. Além dos tempos curtos de análises (<20 min), pela extração em volume reduzido (< 10 mL resíduos orgânicos) este método obedece aos princípios da química verde. Sabe-se que nitrogênio, fósforo, assim como carbono e vitaminas são elementos vitais para o crescimento das microalgas e também exercem influência na composição bioquímica da biomassa. Assim, na terceira etapa deste trabalho, estudou-se a influência das quantidades de nitrato de sódio (75 mg L-1, denominado 1N; 112,5 mg L-1, denominado 1,5N; 225 mg L-1, denominado 3N) e de fosfato monobásico dihidratado (5,65 mg L-1, denominado 1P; 8,47 mg L-1, denominado 1,5P; 16,95 mg L-1, denominado 3P) em meio f/2, que tem como base a água do mar, no crescimento e na síntese de ß-caroteno da Dunaliella salina por processo semicontínuo, com uso de frações de corte (R) de 20% e 80%. Foram obtidas produtividades celulares mais elevadas em processos semicontínuos do que em processo descontínuo, com produtividades médias de até 6,7 x 104 células mL-1 d-1 (meio 1N:1P; R =20%). A máxima concentração celular (Xm) obtida neste trabalho não foi dependente de R. Os melhores resultados de Xm foram obtidos quando se usou meio 1,5N:1,5P em vez de meio, com 1N:1P, com valores médios de até 5,6 x 105 células m L-1 (R =80%). O conteúdo de ß-caroteno nas células, de maneira geral, foi maior nas células cultivadas em meio 1N:1P do que no meio 1,5N:1,5P, com valores até 57,5 mg g-1 (R =80%). O cultivo de D. salina com o meio 3N:3P levou a uma longa fase lag, seguida por uma diminuição na concentração celular e sua lise. O cultivo de células em um fotobiorreator tubular contribuiu para um crescimento celular sem contaminação por protozoários. O cultivo de Dunaliella salina em fotobiorreator tubular com o uso de fotoperíodo 12:12 foi apropriado, assim como induzir a carotenogênese, no segundo estágio, por meio do aumento da intensidade luminosa e ausência de controle de pH


Subject(s)
Carotenoids/pharmacology , Cells, Cultured/metabolism , Aquaculture/classification , Microalgae/metabolism , Data Collection/instrumentation , Chromatography, High Pressure Liquid , Culture , Cell Enlargement , Antioxidants/adverse effects
10.
J Am Med Dir Assoc ; 18(7): 608-615, 2017 Jul 01.
Article in English | MEDLINE | ID: mdl-28377156

ABSTRACT

OBJECTIVE: Protein supplementation increases gains in lean body mass following prolonged resistance-type exercise training in frail older adults. We assessed whether the greater increase in lean body mass can be attributed to muscle fiber type specific hypertrophy with concomitant changes in satellite cell (SC) content. DESIGN: A total of 34 frail elderly individuals (77 ± 1 years, n = 12 male adults) participated in this randomized, double-blind, placebo-controlled trial with 2 arms in parallel. INTERVENTION: Participants performed 24 weeks of progressive resistance-type exercise training (2 sessions per week) during which they were supplemented twice-daily with milk protein (2 × 15 g) or a placebo. METHODS: Muscle biopsies were taken at baseline, and after 12 and 24 weeks of intervention, to determine type I and type II muscle fiber specific cross-sectional area (CSA), SC content, and myocellular characteristics. RESULTS: In the placebo group, a trend for a 20% ± 11% increase in muscle fiber CSA was observed in type II fibers only (P = .051), with no increase in type I muscle fiber CSA. In the protein group, type I and II muscle fiber CSA increased by 23% ± 7% and 34% ± 10% following 6 months of training, respectively (P < .01). Myonuclear domain size increased over time in both groups and fiber types (P < .001), with no significant differences between groups (P > .05). No changes in myonuclear content and SC contents were observed over time in either group (both P > .05). Regression analysis showed that changes in myonuclear content and domain size are predictive of muscle fiber hypertrophy. CONCLUSIONS: Protein supplementation augments muscle fiber hypertrophy following prolonged resistance-type exercise training in frail older people, without changes in myonuclear and SC content.


Subject(s)
Dietary Proteins/administration & dosage , Dietary Supplements , Muscle Fibers, Skeletal/physiology , Muscle Strength/physiology , Muscle, Skeletal/pathology , Resistance Training/methods , Aged , Cell Enlargement , Cell Nucleus Size , Double-Blind Method , Female , Humans , Hypertrophy , Male
11.
Sci Rep ; 6: 38973, 2016 12 12.
Article in English | MEDLINE | ID: mdl-27941867

ABSTRACT

Polydimethylsiloxane (PDMS) is widely used as a cell culture platform to produce micro- and nano-technology based microdevices. However, the native PDMS surface is not suitable for cell adhesion and is always subject to bacterial pollution and cancer cell invasion. Coating the PDMS surface with antibacterial or anticancer materials often causes considerable harm to the non-cancer mammalian cells on it. We have developed a method to fabricate a biocompatible PDMS surface which not only promotes non-cancer mammalian cell growth but also has antibacterial and anticancer activities, by coating the PDMS surface with a Chinese herb extract, paeonol. Coating changes the wettability and the elemental composition of the PDMS surface. Molecular dynamic simulation indicates that the absorption of paeonol onto the PDMS surface is an energy favourable process. The paeonol-coated PDMS surface exhibits good antibacterial activity against both Gram-positive and Gram-negative bacteria. Moreover considerable antibacterial activity is maintained after the coated surface is rinsed or incubated in water. The coated PDMS surface inhibits bacterial growth on the contact surface and promotes non-cancer mammalian cell growth with low cell toxicity; meanwhile the growth of cancer cells is significantly inhibited. Our study will potentially guide PDMS surface modification approaches to produce biomedical devices.


Subject(s)
Acetophenones/pharmacology , Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/pharmacology , Coated Materials, Biocompatible/pharmacology , Dimethylpolysiloxanes/pharmacology , Acetophenones/chemistry , Animals , Cell Enlargement , Coated Materials, Biocompatible/chemistry , Dimethylpolysiloxanes/chemistry , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacology , Escherichia coli/drug effects , HeLa Cells/drug effects , Humans , Materials Testing , Mice , Models, Molecular , Molecular Dynamics Simulation , Surface Properties
12.
ACS Chem Neurosci ; 7(10): 1442-1451, 2016 10 19.
Article in English | MEDLINE | ID: mdl-27467236

ABSTRACT

Neurite outgrowth is crucial during neuronal development and regeneration, and strategies that aim at promoting neuritogenesis are beneficial for reconstructing synaptic connections after neuronal degeneration and injury. Using a bivalent analogue strategy as a successful approach, the current study identifies a series of novel dimeric securinine analogues as potent neurite outgrowth enhancers. Compounds 13, 14, 17-19, and 21-23, with different lengths of carbon chain of N,N-dialkyl substituting diacid amide linker between two securinine molecules at C-15 position, exhibited notable positive effects on both neuronal differentiation and neurite extension of neuronal cells. Compound 14, one of the most active compounds, was used as a representative compound for mechanistic studies. Its action on neurite outgrowth was through phosphorylation/activation of multiple signaling molecules including Ca2+/calmodulin-dependent protein kinase II (CaMKII), extracellular signal-regulated kinase (ERK) and Akt. These findings collectively identify a new group of beneficial compounds for neuritogenesis, and may provide insights on drug discovery of neural repair and regeneration.


Subject(s)
Azepines/chemical synthesis , Azepines/pharmacology , Cell Enlargement/drug effects , Heterocyclic Compounds, Bridged-Ring/chemical synthesis , Heterocyclic Compounds, Bridged-Ring/pharmacology , Neurites/drug effects , Neuroprotective Agents/chemical synthesis , Neuroprotective Agents/pharmacology , Animals , Azepines/chemistry , Blotting, Western , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Cell Line, Tumor , Drug Design , Drug Evaluation, Preclinical , Extracellular Signal-Regulated MAP Kinases/metabolism , Heterocyclic Compounds, Bridged-Ring/chemistry , Immunohistochemistry , Lactones/chemistry , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/physiology , Mice , Molecular Structure , Neurites/physiology , Neuroprotective Agents/chemistry , Phosphorylation/drug effects , Piperidines/chemistry , Proto-Oncogene Proteins c-akt/metabolism
13.
Pharmacol Ther ; 163: 24-47, 2016 07.
Article in English | MEDLINE | ID: mdl-27118336

ABSTRACT

The current research on anticancer drugs focuses on exploiting particular traits or hallmarks unique to cancer cells. Telomerase, a special reverse transcriptase, has been recognized as a common factor in most tumor cells, and in turn a distinctive characteristic with respect to non-malignant cells. This feature has made telomerase a preferred target for anticancer drug development and cancer therapy. This review aims to analyze the pharmacological function and mechanism and role of telomerase in oncogenesis; to provide fundamental knowledge for research on the structure, function, and working mechanism of telomerase; to expound the role that telomerase plays in the initiation and development of tumor and its relationship with tumor cell growth, proliferation, apoptosis, and related pathway molecules; and to display potential targets of antitumor drug for inhibiting the expression, reconstitution, and trafficking of the enzyme. We therefore summarize recent advances in potential telomerase inhibitors for antitumor including natural products, synthetic small molecules, peptides and proteins, which indicate that optimizing the delivery method and drug combination could be of help in a combinatorial drug treatment for tumor. More extensive understanding of the structure, biogenesis, and mechanism of telomerase will provide invaluable information for increasing the efficiency of rational antitumor drug design.


Subject(s)
Antineoplastic Agents/pharmacology , Neoplasms/drug therapy , Telomerase/antagonists & inhibitors , Telomere/metabolism , Animals , Biomarkers , Cell Enlargement , Cell Proliferation , Clinical Trials as Topic , Down-Regulation , Drug Delivery Systems , Drug Design , Holoenzymes , Humans , Plant Preparations/pharmacology , RNA, Messenger/metabolism , Ribonucleoproteins/metabolism , Shelterin Complex , Telomere-Binding Proteins/metabolism , Transcription, Genetic/physiology , Up-Regulation
14.
Biochem Biophys Res Commun ; 470(4): 804-10, 2016 Feb 19.
Article in English | MEDLINE | ID: mdl-26820529

ABSTRACT

Prostaglandins (PGs) play important roles in diverse physiological processes in the central nervous system. PGD2 is the most abundant PG in the brain and acts through specific receptors, DP1 and CRTH2. We investigated the effects of PGD2 on the morphology of the hypothalamic cell line mHypoE-N37 (N37). In N37 cells, serum starvation induced neurite outgrowth and PGD2 elicited neurite retraction, although we failed to detect transcripts for DP1 and CRTH2. Such an effect of PGD2 was efficiently mimicked by its metabolite, 15-deoxy-Δ(12,14)-prostaglandin J2. N-acetyl cysteine completely abolished the effect of PGD2, and reactive oxygen species (ROS) were considered to be important. Notably, neurite outgrowth was restored by PGD2 removal. These results suggest that PGD2 induces reversible neurite retraction in a ROS-mediated mechanism that does not involve any known receptor.


Subject(s)
Cell Enlargement/drug effects , Hypothalamus/cytology , Hypothalamus/metabolism , Neurites/physiology , Prostaglandin D2/administration & dosage , Reactive Oxygen Species/metabolism , Animals , Cell Line , Dose-Response Relationship, Drug , Hypothalamus/drug effects , Mice , Neurites/drug effects , Neurites/ultrastructure
15.
Technol Health Care ; 24(3): 415-27, 2016 May 18.
Article in English | MEDLINE | ID: mdl-26684400

ABSTRACT

The aim of this survey was to provide background theory based on previous research to elucidate the potential pathway by which medical devices using extremely low-frequency high-voltage electric fields (ELF-HVEF) exert therapeutic effects on the human body, and to increase understanding of the AC high-voltage electrotherapeutic apparatus for consumers and suppliers of the relevant devices. Our review revealed that an ELF field as weak as 1-10 µ V/m can induce diverse alterations of membrane proteins such as transporters and channel proteins, including changes in Ca + + binding to a specific site of the cell surface, changes in ion (e.g., Ca + + ) influx or efflux, and alterations in the ligand-receptor interaction. These alterations then induce cytoplasmic responses within cells (Ca + + , cAMP, kinases, etc.) that can have impacts on cell growth, differentiation, and other functional properties by promoting the synthesis of macromolecules. Moreover, increased cytoplasmic Ca + + involves calmodulin-dependent signaling and consequent Ca + + /calmodulin-dependent stimulation of nitric oxide synthesis. This event in turn induces the nitric oxide-cGMP-protein kinase G pathway, which may be an essential factor in the observed physiological and therapeutic responses.


Subject(s)
Electric Stimulation Therapy/methods , Calcium/metabolism , Cell Differentiation , Cell Enlargement , Cyclic AMP/metabolism , Humans , Magnetic Field Therapy/methods , Membrane Transport Modulators/metabolism , Phosphotransferases/metabolism , Signal Transduction
16.
Biomed Mater ; 10(5): 051001, 2015 Oct 20.
Article in English | MEDLINE | ID: mdl-26480959

ABSTRACT

The ability of peripheral nervous system (PNS) axons to regenerate and re-innervate their targets after an injury has been widely recognized. However, despite the considerable advances made in microsurgical techniques, complete functional recovery is rarely achieved, especially for severe peripheral nerve injuries (PNIs). Therefore, alternative therapies that can successfully repair peripheral nerves are still essential. In recent years the use of biodegradable hydrogels enriched with growth-supporting and guidance cues, cell transplantation, and biomolecular therapies have been explored for the treatment of PNIs. Bearing this in mind, the aim of this study was to assess whether Gly-Arg-Gly-Asp-Ser synthetic peptide (GRGDS)-modified gellan gum (GG) based hydrogels could foster an amenable environment for neurite/axonal growth. Additionally, strategies to further improve the rate of neurite outgrowth were also tested, namely the use of adipose tissue derived stem cells (ASCs), as well as the glial derived neurotrophic factor (GDNF). In order to increase its stability and enhance its bioactivity, the GDNF was conjugated covalently to iron oxide nanoparticles (IONPs). The impact of hydrogel modification as well as the effect of the GDNF-IONPs on ASC behavior was also screened. The results revealed that the GRGDS-GG hydrogel was able to support dorsal root ganglia (DRG)-based neurite outgrowth, which was not observed for non-modified hydrogels. Moreover, the modified hydrogels were also able to support ASCs attachment. In contrast, the presence of the GDNF-IONPs had no positive or negative impact on ASC behavior. Further experiments revealed that the presence of ASCs in the hydrogel improved axonal growth. On the other hand, GDNF-IONPs alone or combined with ASCs significantly increased neurite outgrowth from DRGs, suggesting a beneficial role of the proposed strategy for future applications in PNI regenerative medicine.


Subject(s)
Ganglia, Spinal/growth & development , Hydrogels/chemistry , Nerve Regeneration/physiology , Neurites/physiology , Oligopeptides/chemistry , Oligopeptides/pharmacology , Animals , Animals, Newborn , Cell Enlargement , Cells, Cultured , Ganglia, Spinal/cytology , Ganglia, Spinal/drug effects , Materials Testing , Nerve Regeneration/drug effects , Neurites/diagnostic imaging , Neurites/drug effects , Polysaccharides, Bacterial/chemistry , Printing, Three-Dimensional , Rats , Rats, Wistar , Ultrasonography
17.
ACS Chem Neurosci ; 6(8): 1379-92, 2015 Aug 19.
Article in English | MEDLINE | ID: mdl-25939060

ABSTRACT

Ever since the discovery of its neurite growth promoting activity in sympathetic and sensory ganglia, nerve growth factor (NGF) became the prototype of the large family of neurotrophins. The use of primary cultures and clonal cell lines has revealed several distinct actions of NGF and other neurotrophins. Among several models of NGF activity, the clonal cell line PC12 is the most widely employed. Thus, in the presence of NGF, through the activation of the transmembrane protein TrkA, these cells undergo a progressive mitotic arrest and start to grow electrically excitable neuritis. A vast number of studies opened intriguing aspects of NGF mechanisms of action, its biological properties, and potential use as therapeutic agents. In this context, identifying and utilizing small portions of NGF is of great interest and involves several human diseases including Alzheimer's disease. Here we report the specific action of the peptide encompassing the 1-14 sequence of the human NGF (NGF(1-14)), identified on the basis of scattered indications present in literature. The biological activity of NGF(1-14) was tested on PC12 cells, and its binding with TrkA was predicted by means of a computational approach. NGF(1-14) does not elicit the neurite outgrowth promoting activity, typical of the whole protein, and it only has a moderate action on PC12 proliferation. However, this peptide exerts, in a dose and time dependent fashion, an effective and specific NGF-like action on some highly conserved and biologically crucial intermediates of its intracellular targets such as Akt and CREB. These findings indicate that not all TrkA pathways must be at all times operative, and open the possibility of testing each of them in relation with specific NGF needs, biological actions, and potential therapeutic use.


Subject(s)
Nerve Growth Factor/chemistry , Nerve Growth Factor/pharmacology , Neuroprotective Agents/pharmacology , Peptide Fragments/chemistry , Peptide Fragments/pharmacology , Animals , Cell Enlargement/drug effects , Cell Proliferation/drug effects , Cyclic AMP Response Element-Binding Protein/metabolism , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Humans , Molecular Docking Simulation , Nerve Growth Factor/genetics , Neurites/drug effects , Neurites/physiology , Neurogenesis/drug effects , Neuroprotective Agents/chemistry , PC12 Cells , Phosphorylation/drug effects , Rats , Receptor, trkA/metabolism , Time Factors
18.
Mediators Inflamm ; 2014: 870634, 2014.
Article in English | MEDLINE | ID: mdl-25332517

ABSTRACT

Excess of saturated fatty acids in the diet has been associated with obesity, leading to systemic disruption of insulin signaling, glucose intolerance, and inflammation. Macadamia oil administration has been shown to improve lipid profile in humans. We evaluated the effect of macadamia oil supplementation on insulin sensitivity, inflammation, lipid profile, and adipocyte size in high-fat diet (HF) induced obesity in mice. C57BL/6 male mice (8 weeks) were divided into four groups: (a) control diet (CD), (b) HF, (c) CD supplemented with macadamia oil by gavage at 2 g/Kg of body weight, three times per week, for 12 weeks (CD + MO), and (d) HF diet supplemented with macadamia oil (HF + MO). CD and HF mice were supplemented with water. HF mice showed hypercholesterolemia and decreased insulin sensitivity as also previously shown. HF induced inflammation in adipose tissue and peritoneal macrophages, as well as adipocyte hypertrophy. Macadamia oil supplementation attenuated hypertrophy of adipocytes and inflammation in the adipose tissue and macrophages.


Subject(s)
Inflammation/diet therapy , Macadamia , Obesity/diet therapy , Plant Oils/administration & dosage , Adipocytes/pathology , Animals , Cell Enlargement , Cholesterol/blood , Cytokines/biosynthesis , Diet, High-Fat/adverse effects , Inflammation/metabolism , Inflammation/pathology , Insulin Resistance , Macrophages, Peritoneal/metabolism , Macrophages, Peritoneal/pathology , Male , Mice , Mice, Inbred C57BL , Nitric Oxide/metabolism , Obesity/metabolism , Obesity/pathology
19.
Metab Eng ; 25: 183-93, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25088357

ABSTRACT

Polyhydroxyalkanoates (PHA) are intracellularly accumulated as inclusion bodies. Due to the limitation of the cell size, PHA accumulation is also limited. To solve this problem, Escherichia coli was enlarged by over-expression of sulA gene to inhibit the cell division FtsZ ring assembly, leading to the formation of filamentary E. coli that have larger internal space for PHA accumulation compared with rod shape E. coli. As a result, more than 100% increases on poly(3-hydroxybutyrate) (PHB) contents and cell dry weights (CDW) were achieved compared with its control strain under same conditions. The enlarged cell strategy was applied to the production of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) or P(3HB-co-4HB) by sad, gabD, essential genes ispH and folK knockout E. coli harboring two addictives and thus stable plasmids consisting of P(3HB-co-4HB) producing genes, including phaCAB operon, orfZ, 4hbD, sucD, essential genes ispH and folK as well as the sulA. The so constructed E. coli grew in glucose to form filamentary shapes with an improved P(3HB-co-4HB) accumulation around 10% more than its control strain without addition of 4HB precursor, reaching over 78% P(3HB-co-4HB) in CDW. Importantly, the shape changing E. coli was able to precipitate after 20min stillstand. Finally, the filamentary recombinant E. coli was not only able to produce more P(3HB-co-4HB) from glucose but also allow convenient downstream separation from the fermentation broth.


Subject(s)
Escherichia coli Proteins/physiology , Escherichia coli/physiology , Genetic Enhancement/methods , Glucose/metabolism , Hydroxybutyrates/metabolism , Metabolic Engineering/methods , Polyesters/metabolism , Cell Enlargement , Cell Size , Gene Expression Regulation, Bacterial/physiology
20.
BMC Plant Biol ; 14: 197, 2014 Aug 01.
Article in English | MEDLINE | ID: mdl-25080170

ABSTRACT

BACKGROUND: Current views on the control of cell development are anchored on the notion that phenotypes are defined by networks of transcriptional activity. The large amounts of information brought about by transcriptomics should allow the definition of these networks through the analysis of cell-specific transcriptional signatures. Here we test this principle by applying an analogue to comparative anatomy at the cellular level, searching for conserved transcriptional signatures, or conserved small gene-regulatory networks (GRNs) on root hairs (RH) and pollen tubes (PT), two filamentous apical growing cells that are a striking example of conservation of structure and function in plants. RESULTS: We developed a new method for isolation of growing and mature root hair cells, analysed their transcriptome by microarray analysis, and further compared it with pollen and other single cell transcriptomics data. Principal component analysis shows a statistical relation between the datasets of RHs and PTs which is suggestive of a common transcriptional profile pattern for the apical growing cells in a plant, with overlapping profiles and clear similarities at the level of small GTPases, vesicle-mediated transport and various specific metabolic responses. Furthermore, cis-regulatory element analysis of co-regulated genes between RHs and PTs revealed conserved binding sequences that are likely required for the expression of genes comprising the apical signature. This included a significant occurrence of motifs associated to a defined transcriptional response upon anaerobiosis. CONCLUSIONS: Our results suggest that maintaining apical growth mechanisms synchronized with energy yielding might require a combinatorial network of transcriptional regulation. We propose that this study should constitute the foundation for further genetic and physiological dissection of the mechanisms underlying apical growth of plant cells.


Subject(s)
Arabidopsis/metabolism , Plant Roots/metabolism , Pollen/metabolism , Arabidopsis/growth & development , Cell Enlargement , Gene Expression Profiling , Plant Roots/growth & development , Pollen/growth & development , Promoter Regions, Genetic , Transcriptome
SELECTION OF CITATIONS
SEARCH DETAIL